Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
BSGM similar filings
- 2 Jul 20 BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors
- 30 Jun 20 BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering
- 26 Jun 20 ViralClear Partners with Catalent on Potential Treatment for COVID-19
- 26 Jun 20 BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering
- 5 Jun 20 BioSig Technologies’s PURE EP System to be Presented in Heart Rhythm Society 2020 Science Sessions
- 3 Jun 20 U.S. Patent and Trademark Office awards Company additional patent for PURE EP™ System
- 2 Jun 20 Company to provide updates on the initiation of human trials for treatment of adult hospitalized patients with COVID-19
Filing view
External links
Exhibit 16.1
June 26, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated June 26, 2020 of BioSig Technologies, Inc. (the “Company”) and agree with the statements relating only to Liggett & Webb, P.A. contained therein. We have no basis to agree or disagree with other statements of the Company contained therein.
/s/ Liggett & Webb, P.A.